These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21090914)

  • 1. The methodology of visual field testing with frequency doubling technology in the National Health and Nutrition Examination Survey, 2005-2006.
    Terry AL; Paulose-Ram R; Tilert TJ; Johnson CA; Zhang X; Lee PP; Saaddine JB
    Ophthalmic Epidemiol; 2010 Dec; 17(6):411-21. PubMed ID: 21090914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diabetes on glaucoma screening using frequency-doubling perimetry.
    Realini T; Lai MQ; Barber L
    Ophthalmology; 2004 Nov; 111(11):2133-6. PubMed ID: 15522382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the use of frequency doubling technology perimetry in community vision screenings.
    Nehmad L; Madonna RJ
    Optom Vis Sci; 2008 Jul; 85(7):559-65. PubMed ID: 18594349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The validity of screening for open-angle glaucoma in high-risk populations with single-test screening mode frequency doubling technology perimetry (FDT).
    Kamdeu Fansi AA; Li G; Harasymowycz PJ
    J Glaucoma; 2011 Mar; 20(3):167-71. PubMed ID: 20436361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal/noise analysis to compare tests for measuring visual field loss and its progression.
    Artes PH; Chauhan BC
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4700-8. PubMed ID: 19458326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The results of screening frequency doubling technology perimetry in different locations of the community.
    Mansberger SL; Johnson CA; Cioffi GA
    J Glaucoma; 2007 Jan; 16(1):73-80. PubMed ID: 17224754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Frequency-Doubling Technology Perimetry as a Means of Screening for Glaucoma and Other Eye Diseases Using the National Health and Nutrition Examination Survey.
    Boland MV; Gupta P; Ko F; Zhao D; Guallar E; Friedman DS
    JAMA Ophthalmol; 2016 Jan; 134(1):57-62. PubMed ID: 26562502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of frequency doubling technology (FDT) in glaucoma screening.
    Quaranta GM; Vetrugno M; Trabucco T; Cantatore F; Cardia L
    Acta Ophthalmol Scand Suppl; 2000; (232):21-3. PubMed ID: 11235516
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency doubling technology perimetry for the detection of glaucomatous visual field loss.
    Alward WL
    Am J Ophthalmol; 2000 Mar; 129(3):376-8. PubMed ID: 10755955
    [No Abstract]   [Full Text] [Related]  

  • 12. Community visual field screening: prevalence of follow-up and factors associated with follow-up of participants with abnormal frequency doubling perimetry technology results.
    Mansberger SL; Edmunds B; Johnson CA; Kent KJ; Cioffi GA
    Ophthalmic Epidemiol; 2007; 14(3):134-40. PubMed ID: 17613848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of current technology used in evaluating visual function in glaucoma.
    Turalba AV; Grosskreutz C
    Semin Ophthalmol; 2010; 25(5-6):309-16. PubMed ID: 21091017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reliability of frequency-doubling technology (FDT) perimetry in a pediatric population.
    Becker K; Semes L
    Optometry; 2003 Mar; 74(3):173-9. PubMed ID: 12645850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability components of standard automated perimetry and frequency-doubling technology perimetry.
    Spry PG; Johnson CA; McKendrick AM; Turpin A
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1404-10. PubMed ID: 11328758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of frequency-doubling technology for perimetrically normal eyes of open-angle glaucoma patients with unilateral field loss.
    Fan X; Wu LL; Ma ZZ; Xiao GG; Liu F
    Ophthalmology; 2010 Aug; 117(8):1530-7, 1537.e1-2. PubMed ID: 20466428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of community-based glaucoma screening using Frequency Doubling Technology and Heidelberg Retinal Tomography.
    Robin TA; Müller A; Rait J; Keeffe JE; Taylor HR; Mukesh BN
    Ophthalmic Epidemiol; 2005 Jun; 12(3):167-78. PubMed ID: 16036475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of frequency-doubling technology, tendency-oriented perimetry, SITA Standard and SITA Fast perimetry in perimetrically inexperienced individuals.
    Pierre-Filho Pde T; Schimiti RB; de Vasconcellos JP; Costa VP
    Acta Ophthalmol Scand; 2006 Jun; 84(3):345-50. PubMed ID: 16704696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Learning effect in visual field testing of healthy subjects using Humphrey Matrix frequency doubling technology perimetry.
    Pierre-Filho Pde T; Gomes PR; Pierre ET; Pierre LM
    Eye (Lond); 2010 May; 24(5):851-6. PubMed ID: 19680272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities.
    Richman J; Lorenzana LL; Lankaranian D; Dugar J; Mayer JR; Wizov SS; Spaeth GL
    Ophthalmic Epidemiol; 2010 Jun; 17(3):144-51. PubMed ID: 20455843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.